Emissive luminescent, redox-active Ru(II) bischlorido(triphenylphosphine) complexes containing functionalized imidazole tethered thiourea and dithiocarbamate: characterization and preliminary anticancer quantum chemical calculations

Adewale Olufunsho Adeloye, Peter Adewale Ajibade, Damilare David Babatunde, Nomampondo Penelope Magwa

2025

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.1016/j.molstruc.2025.143335
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

ABSTRACT The current paper reports the experimental, photophysical, electrochemical characterization and a preliminary quantum chemical studies evaluation of anti-cancer potential of two mixed-ligand heteroleptic ruthenium(II) complexes containing monodentate 4-imidazoleacrylic acid and bischlorido(triphenylphosphine) tethered with either thiourea or dithiocarbamate moiety obtained in a one-pot reaction synthesis. The complexes formulated as [RuCl 2 (PPh 3 )(dtu)(mza) (OH)]: (Y1) and [RuCl 2 (PPh 3 )(pex)(mza)]: (ZD2), with (dtu = thiourea, mza = 4-imidazole acrylic acid and pex = dithiocarbamate) were characterized by elemental analysis, FT-IR, UV-Vis, PL, 1 H, 13 C, 31 P NMR and MS. The photophysical properties of the two complexes showed appreciable absorption bands at the UV-Vis absorption region wavelengths λ max at (284, 373 nm) and weak absorption maxima at 508 and 638 nm indicative of the presence of π→π*, LLCT and MLTC charge transitions. High intensive photoluminescent emission bands are recorded for both complexes Y1 and ZD2 at λ em 554 and 590 nm respectively, although with Y1 having better luminescent quantum yield (0.71) than ZD2 (0.36) at a common excitation energy. A rapid electrochemical screening study using cyclic voltammogram supported by square-wave voltammogram revealed stronger redox activity negative potential (V) for ZD2 than Y1. Despite the close similarity in chemical structures of the two complexes, the molecular docking/DFT reports showed strong inhibitory constants and binding affinities of complexes Y1 and ZD2 against ERα+ (8DU6) and hFR-β (4KMZ) at –160.749; –142.242 and –144.164; –157.592 respectively when compared to Abemaciclib, being the standard drug at –148.104; –181.067. This work provides firsthand preliminary information on target opportunities aimed at finding new potential bioactive agents with better photostability and high selectivity that could be employed for bioimaging, optical biosensors and/or other emerging applications based on thiourea, dithiocarbamate and 4-imidazoleacrylic acid moieties.